Intra-Hippocampal Transplantation of Neural Precursor Cells with Transgenic Over-Expression of IL-1 Receptor Antagonist Rescues Memory and Neurogenesis Impairments in an Alzheimer’s Disease Model
Authors:
Open Access
- 19 August 2013
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 39 (2) , 401-414
Abstract
Ample evidence implicates neuroinflammatory processes in the etiology and progression of Alzheimer’s disease (AD). To assess the specific role of the pro-inflammatory cytokine interleukin-1 (IL-1) in AD we examined the effects of intra-hippocampal transplantation of neural precursor cells (NPCs) with transgenic over-expression of IL-1 receptor antagonist (IL-1raTG) on memory functioning and neurogenesis in a murine model of AD (Tg2576 mice). WT NPCs- or sham-transplanted Tg2576 mice, as well as naive Tg2576 and WT mice served as controls. To assess the net effect of IL-1 blockade (not in the context of NPCs transplantation), we also examined the effects of chronic (4 weeks) intra-cerebroventricular (i.c.v.) administration of IL-1ra. We report that 12-month-old Tg2576 mice exhibited increased mRNA expression of hippocampal IL-1β, along with severe disturbances in hippocampal-dependent contextual and spatial memory as well as in neurogenesis. Transplantation of IL-1raTG NPCs 1 month before the neurobehavioral testing completely rescued these disturbances and significantly increased the number of endogenous hippocampal cells expressing the plasticity-related molecule BDNF. Similar, but less-robust effects were also produced by transplantation of WT NPCs and by i.c.v. IL-1ra administration. NPCs transplantation produced alterations in hippocampal plaque formation and microglial status, which were not clearly correlated with the cognitive effects of this procedure. The results indicate that elevated levels of hippocampal IL-1 are causally related to some AD-associated memory disturbances, and provide the first example for the potential use of genetically manipulated NPCs with anti-inflammatory properties in the treatment of AD.Keywords
This publication has 62 references indexed in Scilit:
- Concise Review: Can Stem Cells be Used to Treat or Model Alzheimer's Disease?Stem Cells, 2012
- Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signalingBrain, Behavior, and Immunity, 2011
- Mechanisms Underlying Inflammation in NeurodegenerationCell, 2010
- Evidence for a cytokine model of cognitive functionNeuroscience & Biobehavioral Reviews, 2009
- Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppressionMolecular Psychiatry, 2007
- Acetylcholinesterase inhibitors reduce brain and blood interleukin‐1β productionAnnals of Neurology, 2005
- The immune system and memory consolidation: a role for the cytokine IL-1βNeuroscience & Biobehavioral Reviews, 2001
- Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonistAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1999
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.Proceedings of the National Academy of Sciences, 1989